Conference Coverage

VTE risk after bariatric surgery should be assessed


 

REPORTING FROM SAGES 2018


When patients test hypercoagulable at baseline, “we are [now] leaning towards [enoxaparin] 60 mg twice daily,” he said.

Ultimately, anticoagulation TEM could be used to titrate patients into the normal range. For best outcomes, it’s likely that “obese patients require goal-directed therapy instead of weight-based or fixed dosing,” he said, but nothing is going to happen until insurance steps up.

The patients did not have underlying coagulopathies, and 33 (82.5%) were women; the average age was 44 years and average body mass index was 43.6 kg/m2. The mean preop Caprini score was 4, indicating moderate VTE risk. Surgery lasted about 200 minutes. Patients were out of bed and walking on postop day 0.

The investigators had no relevant disclosures.

SOURCE: Urias D et al. World Congress of Endoscopic Surgery hosted by SAGES & CAGS abstract S023.

Pages

Recommended Reading

Chronicity of obesity provides rationale for physician-surgeon collaboration
MDedge Internal Medicine
Gastrectomy mortality risk increased fivefold with same-day discharge
MDedge Internal Medicine
Large database analysis suggests safety of bariatric surgery in seniors
MDedge Internal Medicine
Alcohol use, abuse rise after bariatric surgery
MDedge Internal Medicine
Bariatric surgery comes with some risk of complications
MDedge Internal Medicine
Gastric bypass T2D benefit can fade over time
MDedge Internal Medicine
Sleeve gastrectomy studied as an option for obese HIV-infected patients
MDedge Internal Medicine
Pre–bariatric surgery weight loss improves outcomes
MDedge Internal Medicine
VIDEO: It is an exciting time in obesity treatment
MDedge Internal Medicine
VIDEO: Intestinal remodeling contributes to HbA1c drop after Roux-en-Y gastric bypass
MDedge Internal Medicine